506 related articles for article (PubMed ID: 30646238)
1. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings.
Tucker J; Fischer T; Upjohn L; Mazzera D; Kumar M
JAMA Netw Open; 2018 Oct; 1(6):e183337. PubMed ID: 30646238
[TBL] [Abstract][Full Text] [Related]
2. Continued Risk of Dietary Supplements Adulterated With Approved and Unapproved Drugs: Assessment of the US Food and Drug Administration's Tainted Supplements Database 2007 Through 2021.
White CM
J Clin Pharmacol; 2022 Aug; 62(8):928-934. PubMed ID: 35285963
[TBL] [Abstract][Full Text] [Related]
3. Overview of regulation of dietary supplements in the USA and issues of adulteration with phenethylamines (PEAs).
Pawar RS; Grundel E
Drug Test Anal; 2017 Mar; 9(3):500-517. PubMed ID: 27259162
[TBL] [Abstract][Full Text] [Related]
4. Narrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events.
Li W; Wertheimer A
Innov Pharm; 2023; 14(1):. PubMed ID: 38035313
[No Abstract] [Full Text] [Related]
5. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019.
Wagoner KG; Lazard AJ; Romero-Sandoval EA; Reboussin BA
Cannabis Cannabinoid Res; 2021 Dec; 6(6):559-563. PubMed ID: 34142863
[No Abstract] [Full Text] [Related]
6. Principal component analysis of synthetic adulterants in herbal supplements advertised as weight loss drugs.
Dastjerdi AG; Akhgari M; Kamali A; Mousavi Z
Complement Ther Clin Pract; 2018 May; 31():236-241. PubMed ID: 29705461
[TBL] [Abstract][Full Text] [Related]
7. Adulteration of purported herbal and natural sexual performance enhancement dietary supplements with synthetic phosphodiesterase type 5 inhibitors.
Campbell N; Clark JP; Stecher VJ; Thomas JW; Callanan AC; Donnelly BF; Goldstein I; Kaminetsky JC
J Sex Med; 2013 Jul; 10(7):1842-9. PubMed ID: 23634714
[TBL] [Abstract][Full Text] [Related]
8. Dietary supplements: International legal framework and adulteration profiles, and characteristics of products on the Brazilian clandestine market.
da Justa Neves DB; Caldas ED
Regul Toxicol Pharmacol; 2015 Oct; 73(1):93-104. PubMed ID: 26107294
[TBL] [Abstract][Full Text] [Related]
9. Regulatory alerts for dietary supplements in Canada and the United States, 2005-13.
Abe AM; Hein DJ; Gregory PJ
Am J Health Syst Pharm; 2015 Jun; 72(11):966-71. PubMed ID: 25987692
[TBL] [Abstract][Full Text] [Related]
10. Quantity of phenibut in dietary supplements before and after FDA warnings.
Cohen PA; Ellison RR; Travis JC; Gaufberg SV; Gerona R
Clin Toxicol (Phila); 2022 Apr; 60(4):486-488. PubMed ID: 34550038
[TBL] [Abstract][Full Text] [Related]
11. An overview of herb and dietary supplement efficacy, safety and government regulations in the United States with suggested improvements. Part 1 of 5 series.
Brown AC
Food Chem Toxicol; 2017 Sep; 107(Pt A):449-471. PubMed ID: 27818322
[TBL] [Abstract][Full Text] [Related]
12. Study on health hazards through medicines purchased on the Internet: a cross-sectional investigation of the quality of anti-obesity medicines containing crude drugs as active ingredients.
Yoshida N; Numano M; Nagasaka Y; Ueda K; Tsuboi H; Tanimoto T; Kimura K
BMC Complement Altern Med; 2015 Dec; 15(1):430. PubMed ID: 26637485
[TBL] [Abstract][Full Text] [Related]
13. Banned and discouraged-use ingredients found in weight loss supplements.
Eichner S; Maguire M; Shea LA; Fete MG
J Am Pharm Assoc (2003); 2016; 56(5):538-43. PubMed ID: 27475836
[TBL] [Abstract][Full Text] [Related]
14. The scoop on brain health dietary supplement products containing huperzine A.
Crawford C; Wang YH; Avula B; Bae JY; Khan IA; Deuster PA
Clin Toxicol (Phila); 2020 Oct; 58(10):991-996. PubMed ID: 31990212
[No Abstract] [Full Text] [Related]
15. Dietary supplements: What's in a name? What's in the bottle?
Marcus DM
Drug Test Anal; 2016; 8(3-4):410-2. PubMed ID: 27072845
[TBL] [Abstract][Full Text] [Related]
16. Screening and Determination of Synthetic PDE-5 Inhibitors in Adulterated Sexual Enhancement Supplements.
Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; Ibrahim B; Zyoud SH
Molecules; 2022 Oct; 27(19):. PubMed ID: 36235271
[TBL] [Abstract][Full Text] [Related]
17. A Public Health Issue: Dietary Supplements Promoted for Brain Health and Cognitive Performance.
Crawford C; Boyd C; Avula B; Wang YH; Khan IA; Deuster PA
J Altern Complement Med; 2020 Apr; 26(4):265-272. PubMed ID: 32119795
[No Abstract] [Full Text] [Related]
18. A Systematic Review of the European Rapid Alert System for Food and Feed: Tendencies in Illegal Food Supplements for Weight Loss.
Koncz D; Tóth B; Roza O; Csupor D
Front Pharmacol; 2020; 11():611361. PubMed ID: 33574758
[No Abstract] [Full Text] [Related]
19. The POWER saga from 2007 to 2022: An example of a sexual enhancement dietary supplement tainted by different adulterants and still on the market.
Balayssac S; Danoun S; Gilard V; Martino R; Malet-Martino M
J Pharm Biomed Anal; 2023 Apr; 227():115283. PubMed ID: 36780864
[TBL] [Abstract][Full Text] [Related]
20. The Role of Adverse Event Reporting in the FDA Response to a Multistate Outbreak of Liver Disease Associated with a Dietary Supplement.
Klontz KC; DeBeck HJ; LeBlanc P; Mogen KM; Wolpert BJ; Sabo JL; Salter M; Seelman SL; Lance SE; Monahan C; Steigman DS; Gensheimer K
Public Health Rep; 2015; 130(5):526-32. PubMed ID: 26327730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
